[PDF][PDF] The year in cardiology 2016: acute coronary syndromes.
F Crea, RK Binder, TF Lüscher - Cardiologia Croatica, 2017 - hrcak.srce.hr
DRUG AND MATERIAL DISCLAIMER: The mention of trade names, commercial products
organizations, and the inclusion of advertisements in the journal does not imply …
organizations, and the inclusion of advertisements in the journal does not imply …
Prognostic implications of Q waves at presentation in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary …
Background Presence of Q waves on the presenting electrocardiogram (ECG) in patients
with ST‐segment elevation myocardial infarction (STEMI) has been associated with worse …
with ST‐segment elevation myocardial infarction (STEMI) has been associated with worse …
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 …
C Hengstenberg, J Chandrasekhar… - Catheterization and …, 2017 - Wiley Online Library
Background Prior studies have suggested that patients with atrial fibrillation (AF) undergoing
transcatheter aortic valve replacement (TAVR) are at higher risk for adverse cardiovascular …
transcatheter aortic valve replacement (TAVR) are at higher risk for adverse cardiovascular …
Influence of minor deterioration of renal function after PCI on outcome in patients with ST‐elevation myocardial infarction
V Kanic, D Suran, M Vollrath… - Journal of …, 2017 - Wiley Online Library
Objectives Our aim was to assess the possible impact of a deterioration of renal function
(DRF) not fulfilling the criteria for acute kidney injury after percutaneous coronary …
(DRF) not fulfilling the criteria for acute kidney injury after percutaneous coronary …
Procedural anticoagulation in myocardial infarction
GW Stone - New England Journal of Medicine, 2017 - Mass Medical Soc
The prognosis for patients with ST-segment elevation myocardial infarction (STEMI) and non-
STEMI (NSTEMI) is improved with the use of percutaneous coronary intervention (PCI) …
STEMI (NSTEMI) is improved with the use of percutaneous coronary intervention (PCI) …
How long does it take for clopidogrel and ticagrelor to inhibit platelets in patients undergoing primary percutaneous coronary intervention? A detailed …
TO Bergmeijer, TC Godschalk… - … in Thrombosis and …, 2017 - thieme-connect.com
Antiplatelet therapy plays a pivotal role in patients with an ST-segment elevation myocardial
infarction (STEMI) to prevent further atherothrombotic events, such as stent thrombosis …
infarction (STEMI) to prevent further atherothrombotic events, such as stent thrombosis …
Antithrombotic therapy for ACS in elderly patients
V Roule, K Blanchart, X Humbert, D Legallois… - … Drugs and Therapy, 2017 - Springer
Background Patients over 75 account for more than one third of those presenting with
myocardial infarction and more than 50% of intrahospital mortality. There are no specific …
myocardial infarction and more than 50% of intrahospital mortality. There are no specific …
比伐卢定在高龄急性ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中的疗效观察
姜阳， 郑晓群， 林海龙 - 临床心血管病杂志, 2017 - whuhzzs.com
目的: 观察在年龄> 70 岁的急性ST 段抬高型心肌梗死(STEMI) 患者经皮冠状动脉介入治疗(PCI)
术中应用比伐卢定抗凝的安全性及疗效. 方法: 采用回顾性病例对照研究, 收集2016-01-2017-01 …
术中应用比伐卢定抗凝的安全性及疗效. 方法: 采用回顾性病例对照研究, 收集2016-01-2017-01 …
Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in …
H Wang, Y Li, H Cong, S Ding, B Liu… - Catheterization and …, 2017 - Wiley Online Library
Objectives: To explore the efficiency and safety of bivalirudin in patients undergoing
emergency percutaneous coronary intervention via radial access. Background: Bivalirudin …
emergency percutaneous coronary intervention via radial access. Background: Bivalirudin …